The clinical and laboratory characteristics of secondary HLH reflect tissue infiltration of activated immune cells, especially CD8+ T lymphocytes and macrophages, as well as local and systematic effects of various inflammatory cytokines, such as interferon-γ, tumor necrosis factor-α, interleukin-1β, and interleukin-6 (19). Here, IL6 is linked to hemophagocytic syndrome.